glp-1-directed nmda receptor antagonism for obesity treatment A metabolic balance of GLP-1 and receptors in the brain New Developments in Pharmacological Treatment

No drama, no discomfort, just fiber quietly doing its thing

While chronic exposure to GLP-1Ra appears to be essentially neutral on both systolic and diastolic function, irrespective of left ventricular ejection fraction (LVEF), a beneficial impact of SGLT-2i is consistently detectable for both systolic and diastolic function parameters in subjects with diabetes with and without HF, with a gradient proportional to the severity of baseline dysfunction

Generalist nutrition apps MyFitnessPal, Cronometer bring mature food databases and have added GLP-1 medication features on top

Pitfalls in the analysis of the physiological antioxidant glutathione (GSH) and its disulfide (GSSG) in biological samples: an elephant in the room

Fearon KC

When the medication is initially prescribed, starting low and going slow can also help your patients better tolerate any GI symptoms associated with GLP-1RAs. A better understanding of the side effects is key when prescribing any medication, and it is equally important to raise patient awareness